Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study.
Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study. Blood. 2020 08 06; 136(6):674-683.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Area Under Curve
Capsules
Cross-Over Studies
Disease Progression
DNA Methylation
DNA-Cytosine Methylases
Drug Combinations
Drug Monitoring
Female
Gastrointestinal Diseases
Hematologic Diseases
Humans
Kaplan-Meier Estimate
Least-Squares Analysis
Leukemia, Myeloid, Acute
Leukemia, Myelomonocytic, Chronic
Long Interspersed Nucleotide Elements
Male
Middle Aged
Myelodysplastic Syndromes
Neoplasm Proteins
Tablets
Uridine
authors with profiles
Olatoyosi Odenike